Status:

ACTIVE_NOT_RECRUITING

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

Lead Sponsor:

AbbVie

Conditions:

Atrophic Acne Scars

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Visit the study website https://dawnacnescarstudy.com/ACT for more information. Atrophic acne scars are flat, indented or with an inverted center scars that develop at the endpoint of the normal heali...

Eligibility Criteria

Inclusion

  • Participants in general good health, with no active COVID-19 infection, and seeking improvement of atrophic acne scars.
  • Moderate to severe atrophic acne scarring (Grade 4 or 5 on the Allergan ASIS) on each cheek based on Evaluating Investigator's live assessment (both cheeks must qualify but do not need to have the same score) at the first screening visit.
  • At least 5 rolling or boxcar-type acne scars in total within the predefined assessment field of either cheek in areas of otherwise normal healthy skin, as assessed by the treating investigator.

Exclusion

  • The participant has clinically significant acne on the face.
  • Current cutaneous or mucosal inflammatory or infectious processes other than acne (eg, herpes), rosacea, abscess, an unhealed wound, or a cancerous or precancerous lesion, on the face.
  • The participant presents with predominantly ice pick scars.
  • History of keloid scar formation, hypertrophic scarring and/or post inflammatory hyperpigmentation or hypopigmentation.
  • History of granulomatous or connective tissue disease.
  • Diagnosed autoimmune disease (eg, Type 1 diabetes, rheumatoid arthritis, scleroderma, vitiligo).
  • Diagnosed history of lung disease.
  • Known hypersensitivity to the constituents of the device.
  • Visual acuity of 20/100 or worse or abnormal confrontational visual fields or ocular motility.

Key Trial Info

Start Date :

November 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2026

Estimated Enrollment :

157 Patients enrolled

Trial Details

Trial ID

NCT05995340

Start Date

November 21 2023

End Date

August 1 2026

Last Update

June 6 2025

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Alberta DermaSurgery Centre /ID# 243168

Edmonton, Alberta, Canada, T6G 1C3

2

Humphrey & Beleznay Cosmetic Dermatology /ID# 266634

Vancouver, British Columbia, Canada, V5Z 4E1

3

Pacific Derm /ID# 227467

Vancouver, British Columbia, Canada, V6H 4E1

4

Dermetics Cosmetic Dermatology /ID# 227469

Burlington, Ontario, Canada, L7N 3N2